GPATWNasdaqBlank ChecksUS GAAP · USD

GP-Act III Acquisition Corp.

GP-Act III Acquisition Corp. is a special purpose acquisition company (SPAC) formed to identify and merge with an operating business that has not yet been selected. It has no commercial operations of its own and exists to use IPO proceeds, trust-account funds, and related financing to complete a business combination before its liquidation deadline.

Operating profit (EBIT)-0.6m USD
+2.3 %y/y
Net income11.9m USD
+37.1 %y/y

Fiscal year 2025 · change from previous year

Development 2023–2025

-0.6-0.4-0.20.0m USD2023: EBIT -0.01 m USD20232024: EBIT -0.56 m USD20242025: EBIT -0.55 m USD2025-0.55
RevenueOperating profit (EBIT)

Business

Share of revenue
Blank check acquisition vehicle100 %

A publicly listed shell company formed to acquire an unidentified target business.

Customers

The company does not sell products or services to end customers; its counterparties are the target businesses it seeks to acquire and the capital providers that funded the SPAC. The practical 'customer' is the private company that may choose to combine with GP-Act III to access public markets, cash, and a listing platform. Sponsor, co-sponsors, and underwriters are also economically important stakeholders because they provide financing, support, and transaction incentives.

Target operating businesses

Private companies that may merge with the SPAC to become public and access cash.

Sponsor and co-sponsors

Provide support, potential loans, and transaction sponsorship to keep the SPAC active.

Public shareholders

Invest in the SPAC units and ultimately vote on or redeem around a business combination.

Strategy

The company’s core strategy is to complete an initial business combination before the May 13, 2026 deadline and avoid mandatory liquidation. Management is using trust-account proceeds, sponsor support, and potential debt or equity financing to pursue a target while controlling public-company and due-diligence costs. Success depends on identifying a suitable business, negotiating terms, and closing within the required timeframe.

Complete a business combination before the deadlineShort term

Without a transaction, the company must liquidate and dissolve.

Maintain liquidity and transaction optionalityShort term

The company has limited cash outside the trust account and may need extra funding for diligence and overhead.

Geography

GP-Act III is incorporated in the Cayman Islands but operates as a U.S.-listed acquisition vehicle with its cash held in a trust account and its public-company activities centered in the United States. The company’s geographic exposure is therefore driven less by operating footprint and more by where it finds a target business and where that target conducts its business after a merger. No country-level revenue disclosure is available because the company has not yet generated operating revenue.

Risks

The main risk is execution: the company may fail to identify, negotiate, finance, and close a suitable acquisition before the liquidation deadline. As a SPAC with no operating revenue, it is also exposed to financing risk, redemption risk, and the possibility that trust-account funds and sponsor support are insufficient to complete a transaction. If no deal closes, shareholders face liquidation rather than an operating business investment.

Sorted by severity
Failure to complete a business combinationCritical

The company has a fixed deadline and no operating business to fall back on.

ExposureMay 132026 liquidation deadline
Liquidity shortfall before closing a transactionHigh

Cash outside the trust account is limited and additional financing is uncertain.

ExposureWorking capitalDiligencePublic-company costs
Sponsor and insider funding is discretionaryHigh

Loans or investments from sponsors and insiders are not obligated and may not materialize.

Exposure: Short-term operating runway

Redemptions reduce cash available for acquisitionHigh

Public shareholders may redeem shares around a proposed combination, shrinking deal capital.

Exposure: Transaction financing

Accounting

Judgemental items
Trust account accounting

Interest income and restricted cash balances affect reported earnings and liquidity presentation.

Impact: Non-operating income and cash available for a transaction

Deferred underwriting fee

The $13.6875 million deferred fee is contingent on closing a business combination.

Impact: Transaction cost and cash outflow at closing

Going concern assessment

Management concluded liquidation risk raises substantial doubt if no deal closes.

Impact: Financial statement disclosure and investor risk assessment

Warrant and share-class accounting

Classification and dilution treatment affect EPS and equity presentation.

Impact: Per-share results and balance sheet classification

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

GP-Act III Acquisition Corp. (Nasdaq) – Blank Checks | Financial Analysis – Clarifo